This activity is designed for medical oncologists, radiation oncologists, and other healthcare professionals interested in managing patients with GC.
Disclosure of Conflicts of Interest
It is the policy of the Elsevier Office of Continuing Medical Education that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Faculty or Presenter
Relationship Identified With:
Charles S. Fuchs, MD, MPH, FACP
Consultant/Advisor: Amgen, Inc.; Bristol-Myers Squibb Company; Eli Lilly and Company; MedImmune, Inc.; Merck & Co., Inc.; Pfizer, Inc.; sanofi-aventis
Non-Faculty: Tara Frate; Sara Sloan; Sandy Breslow; Bernard Abrams, MD; and Alison Kemp hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Janardhan Sampath, PhD, hereby states that his spouse/life partner is employed by Amgen, Inc.
This activity has been supported by an independent educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Jointly provided by the Elsevier Office of Continuing Medical Education and ACCELMED.
CME Credit (Physicians)
The Elsevier Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Elsevier Office of Continuing Medical Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Inquiries/Special Needs
For all CME inquiries or special needs, please contact elsevierCME@elsevier.com.
Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Elsevier Office of Continuing Medical Education, ACCELMED, and Lilly do not recommend the use of any agent outside of the labeled indications.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.